Study Evaluating the Nasopharyngeal Carriage in Healthy Children
NCT00768833 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 242
Last updated 2014-08-21
Summary
The purpose of this study is to assess the prevalence of pneumococcal stereotypes in the nasopharynx of healthy children and to describe the changes of nasopharyngeal carriage at different ages over time.
Conditions
- Healthy Subjects
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 3 Months
- Max Age
- 4 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-10-31
- Primary Completion
- 2014-08-31
- Completion
- 2014-08-31
Countries
- Germany
Study Locations
More Related Trials
-
Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
NCT00307541 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of Pneumococci
NCT01040143 ·Status: COMPLETED
-
Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A
NCT00839254 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool Asthmatics
NCT00836641 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Carriage of Pneumococci in Children Aged ≤8 Years, and Their Household Contacts
NCT03407690 ·Status: COMPLETED
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Japanese Infants
NCT00574795 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Memory Evaluation in Children Following a Primary Vaccination With Pneumococcal Conjugate Vaccines.
NCT00333450 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Natural Antibody Response to Pneumococcal Surface Proteins During Acute Otitis Media in Children
NCT01214538 ·Status: UNKNOWN
-
Study Evaluating Prevenar in High-Risk Children
NCT00234338 ·Status: COMPLETED
-
PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
NCT02133469 ·Status: COMPLETED ·Phase: NA
-
Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children
NCT00950833 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine
NCT00345358 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage
NCT01925222 ·Status: COMPLETED
-
Streptococcus Pneumonia: Effects of PCV13 on Pneumococcal Carriage
NCT01109108 ·Status: COMPLETED
-
Phase I to Test a New Pneumococcal Vaccine
NCT03303976 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating the Impact of a 13-valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization
NCT00508742 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 Years
NCT00761631 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants.
NCT00366340 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage
NCT00294021 ·Status: COMPLETED
-
A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese Infants and Young Children
NCT03574389 ·Status: COMPLETED ·Phase: PHASE3
-
PCV13 in Non-pregnant Papua New Guinean Women
NCT04183322 ·Status: COMPLETED
-
Study of Two Investigational Pneumococcal Vaccines in Healthy Adults
NCT01444339 ·Status: COMPLETED ·Phase: PHASE1
-
Prevalence of Nasopharyngeal Carriage of Streptococcus Pneumoniae in Healthy Children of 12-18 Months in 6 Cities, China
NCT00952367 ·Status: COMPLETED
-
Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
NCT01444352 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing Prevenar® to Pneumo 23 in Reducing Carriage in Children
NCT00580684 ·Status: COMPLETED ·Phase: PHASE4